Polycystic liver disease

Polycystic liver disease (PLD) is a rare genetic disorder characterized by the presence of multiple cysts scattered throughout the liver. These cysts can vary in size and number, and while they are generally benign, they can lead to complications and affect liver function.
Etiology
PLD is primarily associated with two genetic conditions: autosomal dominant polycystic kidney disease (ADPKD) and autosomal dominant polycystic liver disease (ADPLD). In ADPKD, cysts are present in both the kidneys and the liver, whereas in ADPLD, cysts are confined to the liver.
Pathophysiology
The cysts in PLD arise from the biliary epithelium and are filled with fluid. The exact mechanism of cyst formation is not fully understood, but it is believed to involve abnormalities in the polycystin proteins, which play a role in cell signaling and the structural integrity of the biliary epithelium.
Clinical Presentation
Many individuals with PLD are asymptomatic and may not require treatment. However, symptoms can occur if the cysts become large or numerous enough to cause complications. Common symptoms include:
- Abdominal pain or discomfort
- Bloating
- Early satiety
- Nausea
In severe cases, complications such as cyst infection, hemorrhage, or rupture can occur.
Diagnosis
PLD is typically diagnosed through imaging studies such as ultrasound, computed tomography (CT), or magnetic resonance imaging (MRI). These imaging modalities can reveal the size, number, and distribution of liver cysts.
Treatment
Treatment for PLD is generally conservative and focuses on managing symptoms. Options include:
- Pain management with analgesics
- Aspiration of cyst fluid
- Sclerotherapy
- Surgical intervention in severe cases, such as cyst fenestration or liver transplantation
Prognosis
The prognosis for individuals with PLD varies. Many individuals live normal lives without significant liver dysfunction. However, in cases where PLD is associated with ADPKD, the prognosis may be influenced by the severity of kidney disease.
Related Pages
- Autosomal dominant polycystic kidney disease
- Autosomal dominant polycystic liver disease
- Liver cyst
- Liver transplantation
See Also
References
External Links
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
- Budget GLP-1 shots
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian